Dr. Bryon Adinoff, MD

---

DEA Turmoil in Rescheduling Cannabis: How It Works and Does It Matter?

Dr. Bryon Adinoff, MD, President, Doctors for Drug Policy Reform (D4DPR)

The Drug Enforcement Administration (DEA) has been at the center of controversy as it navigates the potential rescheduling of cannabis under federal law. This presentation will explore the process behind DEA rescheduling decisions, the scientific and political factors influencing the current debate, and what rescheduling would actually mean in practice. Attendees will gain a clear understanding of how rescheduling works, who holds the power, and whether a shift in classification would have meaningful impacts on medical access, research, and the cannabis industry at large.

Bryon Adinoff, MD is an addiction psychiatrist, neuroscientist, academician, and advocate. He was appointed Clinical Professor at the University of Colorado School of Medicine following his retirement as Distinguished Professor of Alcohol and Drug Abuse Research in the Department of Psychiatry at the University of Texas Southwestern Medical Center and as a psychiatrist for 30 years with the Department of Veterans Affairs. He has published over 200 papers and book chapters on the neurobiology and treatment of addiction and is Editor-in-Chief of The American Journal of Drug and Alcohol Abuse. In his semi-retired status, he has evolved from focusing on the consequences of substance use itself to the consequences of drug prohibition. His commitment to the goals of D4DPR arises from his desire to ensure that the devastating effects of the global drug war are replaced by a science-based, compassionate, and just system that protects both the individual and society.